Lecture 7-Kumar Enzyme Inhibition-Drug Discovery Aspirin (anti-inflammatory) Penicillin (effective...

19
Lecture 7-Kumar Enzyme Inhibition-Drug Discovery Aspirin (anti-inflammatory) Penicillin (effective against gram positive bacteria) Sulfonamides (anti-diarrhea) Anti HIV drugs 1

Transcript of Lecture 7-Kumar Enzyme Inhibition-Drug Discovery Aspirin (anti-inflammatory) Penicillin (effective...

Page 1: Lecture 7-Kumar Enzyme Inhibition-Drug Discovery Aspirin (anti-inflammatory) Penicillin (effective against gram positive bacteria) Sulfonamides (anti-diarrhea)

Lecture 7-KumarEnzyme Inhibition-Drug Discovery

• Aspirin (anti-inflammatory)• Penicillin (effective against gram positive

bacteria)• Sulfonamides (anti-diarrhea)• Anti HIV drugs

1

Page 2: Lecture 7-Kumar Enzyme Inhibition-Drug Discovery Aspirin (anti-inflammatory) Penicillin (effective against gram positive bacteria) Sulfonamides (anti-diarrhea)

2

ENZYME INHIBITORS AS DRUGS

• Competitive Inhibitors compete with the substrate for the active site

• Non-Competitive inhibitors bind near but not at the active site

• Irreversible inhibitors bind at the active site of the enzyme and form a covalent bond with a group at this site

Page 3: Lecture 7-Kumar Enzyme Inhibition-Drug Discovery Aspirin (anti-inflammatory) Penicillin (effective against gram positive bacteria) Sulfonamides (anti-diarrhea)

Enzyme inhibition

3

Page 4: Lecture 7-Kumar Enzyme Inhibition-Drug Discovery Aspirin (anti-inflammatory) Penicillin (effective against gram positive bacteria) Sulfonamides (anti-diarrhea)

COMPETITIVE INHIBITORS

E + S ES E + P+I

EIKi= [E][I]/[EI]

V= Vmax S Km[1+(I/Ki)] +S

4

Page 5: Lecture 7-Kumar Enzyme Inhibition-Drug Discovery Aspirin (anti-inflammatory) Penicillin (effective against gram positive bacteria) Sulfonamides (anti-diarrhea)

Kinetics of competitive inhibitor bindingIncrease [S] toovercomeinhibition

Vmax attainable,Apparent Km is increased

Ki =dissociationconstant forinhibitor

5

Page 6: Lecture 7-Kumar Enzyme Inhibition-Drug Discovery Aspirin (anti-inflammatory) Penicillin (effective against gram positive bacteria) Sulfonamides (anti-diarrhea)

Vmax unaltered, Km increased Double reciprocal plot in the

presence of a competitive inhibitor

6

Page 7: Lecture 7-Kumar Enzyme Inhibition-Drug Discovery Aspirin (anti-inflammatory) Penicillin (effective against gram positive bacteria) Sulfonamides (anti-diarrhea)

Methotrexate in cancer chemotherapy

7

Page 8: Lecture 7-Kumar Enzyme Inhibition-Drug Discovery Aspirin (anti-inflammatory) Penicillin (effective against gram positive bacteria) Sulfonamides (anti-diarrhea)

COMPETITIVE INHIBITORS AS DRUGS

Adenine Thioadenine

8

Page 9: Lecture 7-Kumar Enzyme Inhibition-Drug Discovery Aspirin (anti-inflammatory) Penicillin (effective against gram positive bacteria) Sulfonamides (anti-diarrhea)

More competitive inhibitors as drugs

• Doxycycline– competitive inhibitor of collagenase- control of

periodontal disease

• AZT-competitive inhibitor of HIV RT• Mozenavir and Tipranavir

competitive inhibitors of HIV protease• Allopurinol (used in gout)—Oxypurinol—inhibits

xanthine oxidase

9

Page 10: Lecture 7-Kumar Enzyme Inhibition-Drug Discovery Aspirin (anti-inflammatory) Penicillin (effective against gram positive bacteria) Sulfonamides (anti-diarrhea)

ENZYME INHIBITORS IN CLINICAL USE • A clinical application in Periodontitis

10

Page 11: Lecture 7-Kumar Enzyme Inhibition-Drug Discovery Aspirin (anti-inflammatory) Penicillin (effective against gram positive bacteria) Sulfonamides (anti-diarrhea)

NONCOMPETITIVE INHIBITION

E + S ES E + P+ +I I

EI + S ESI

Vmax SV= [1+(I/Ki)] Km + S

11

Page 12: Lecture 7-Kumar Enzyme Inhibition-Drug Discovery Aspirin (anti-inflammatory) Penicillin (effective against gram positive bacteria) Sulfonamides (anti-diarrhea)

Kinetics of non-competitive inhibitionIncreasing [S] cannotovercome inhibition

Less E available,Vmax is lower,Km remains the samefor available E

12

Page 13: Lecture 7-Kumar Enzyme Inhibition-Drug Discovery Aspirin (anti-inflammatory) Penicillin (effective against gram positive bacteria) Sulfonamides (anti-diarrhea)

Noncompetitive inhibition

Km unaltered, Vmax decreased

13

Page 14: Lecture 7-Kumar Enzyme Inhibition-Drug Discovery Aspirin (anti-inflammatory) Penicillin (effective against gram positive bacteria) Sulfonamides (anti-diarrhea)

Non-competitive inhibitors as drugs

• Fluoride: Non-competitive inhibitor of enolase

• Non-nucleoside compounds as inhibitors of HIV RT

14

Page 15: Lecture 7-Kumar Enzyme Inhibition-Drug Discovery Aspirin (anti-inflammatory) Penicillin (effective against gram positive bacteria) Sulfonamides (anti-diarrhea)

Kinetics of irreversible inhibition

15

Page 16: Lecture 7-Kumar Enzyme Inhibition-Drug Discovery Aspirin (anti-inflammatory) Penicillin (effective against gram positive bacteria) Sulfonamides (anti-diarrhea)

EXAMPLES OF IRREVERSIBLE INHIBITORS AS DRUGS

16

Page 17: Lecture 7-Kumar Enzyme Inhibition-Drug Discovery Aspirin (anti-inflammatory) Penicillin (effective against gram positive bacteria) Sulfonamides (anti-diarrhea)

Amoxicillin and Clavulinic Acid

17

Page 18: Lecture 7-Kumar Enzyme Inhibition-Drug Discovery Aspirin (anti-inflammatory) Penicillin (effective against gram positive bacteria) Sulfonamides (anti-diarrhea)

Irreversible Inhibitors

• Emphysema: Alpha-1-Antitrypsin deficiency—This protein inhibitor irreversibly inactivates elastase

• Nerve Gas: Sarin—irreversibly inhibits acetylcholinesterase and conversion of acetylcholine to choline and acetic acid

• Anticancer Drug: 5-Fluorouracil—irreversibly inhibits thymidylate synthetase

18

Page 19: Lecture 7-Kumar Enzyme Inhibition-Drug Discovery Aspirin (anti-inflammatory) Penicillin (effective against gram positive bacteria) Sulfonamides (anti-diarrhea)

Lecture 7-Learning objectives

• Recognize the differences between competitive, non-competitive and irreversible inhibitors

• Know how each of the inhibitors affects Km and Vmax

• Know the importance of inhibition constant in drug design and discovery

• Be knowledgeable about some of the drugs currently on the market

19